The test examines key variants including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313each influencing appetite regulation, metabolic rate, and medication responsiveness
Instead, our focus is on medications like Wegovy, Zepbound, and Foundayo, each specifically approved for weight management
doi: 10.3390/nu13062113 205 ODriscollM.Ribeiro Dos SantosG.WangL.CummingsD
Key Background Researchers have studied for years whether GLP-1 drugs could reduce bone density, after previous studies suggested people with obesity and type 2 diabetes likely have less bone mass
Neuroscience Letters, 2008
148,149 Proliferating cancer cells exhibit aerobic glycolysis, leading to a shift in glucose carbon away from the TCA cycle, which results in the increased use of glutamine to fuel anabolic processes to support rapid cell growth with increased NADPH and ammonia generation